Acquired resistance to EGFR tyrosine kinase inhibitor in A431 squamous cell carcinoma xenografts is mediated by c-Kit pathway transduction

Tumor Biology ◽

10.1007/s13277-014-2932-7 ◽

2014 ◽

Vol 36 (4) ◽

pp. 2993-2999 ◽

Author(s):

Lixia Zhang ◽

Xiaokun Yang ◽

Bei Zhao ◽

Zhen Cai

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor

Journal of Clinical Pathology ◽

10.1136/jclinpath-2015-202866 ◽

2015 ◽

Vol 68 (4) ◽

pp. 320-321 ◽

Author(s):

Justine L Kuiper ◽

Merle I Ronden ◽

Annemarie Becker ◽

Daniëlle A M Heideman ◽

Peter van Hengel ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Nsclc Patient ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Download Full-text

EGFR Tyrosine Kinase Inhibitor Pelitinib Regulates Radiation-Induced p65-Dependent Telomerase Activation in Squamous Cell Carcinoma

Radiation Research ◽

10.1667/rr3028.1 ◽

2013 ◽

Vol 179 (3) ◽

pp. 304-312 ◽

Author(s):

Natarajan Aravindan ◽

Sheeja Aravindan ◽

Terence S. Herman ◽

Mohan Natarajan

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Radiation Induced

Download Full-text

Deguelin Potentiates Apoptotic Activity of an EGFR Tyrosine Kinase Inhibitor (AG1478) in PIK3CA-Mutated Head and Neck Squamous Cell Carcinoma

International Journal of Molecular Sciences ◽

10.3390/ijms18020262 ◽

2017 ◽

Vol 18 (2) ◽

pp. 262 ◽

Author(s):

Yuh Baba ◽

Toyonobu Maeda ◽

Atsuko Suzuki ◽

Satoshi Takada ◽

Masato Fujii ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Neck Squamous Cell Carcinoma ◽

Egfr Tyrosine Kinase Inhibitor ◽

Apoptotic Activity

Download Full-text

Anlotinib Hydrochloride Combined With EGFR-Tyrosine Kinase Inhibitor (TKI) in Treating Advanced NSCLC Patients With Acquired Resistance to EGFR-TKI

Case Medical Research ◽

10.31525/ct1-nct04007835 ◽

2019 ◽

Author(s):

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Advanced Nsclc ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Nsclc Patients ◽

Download Full-text

EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.

International Journal of Oncology ◽

10.3892/ijo.13.2.335 ◽

1998 ◽

Author(s):

H Modjtahedi ◽

K Affleck ◽

C Stubberfield ◽

C Dean

Keyword(s):

Monoclonal Antibody ◽

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Terminal Differentiation ◽

Human Squamous Cell Carcinoma

Download Full-text

Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling

Breast Cancer Research and Treatment ◽

10.1007/s10549-007-9830-2 ◽

2007 ◽

Vol 112 (1) ◽

pp. 25-33 ◽

Author(s):

Nicola Normanno ◽

Manuela Campiglio ◽

Monica R. Maiello ◽

Antonella De Luca ◽

Mario Mancino ◽

...

Keyword(s):

Breast Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cells ◽

Breast Cancer Cells ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Mapk Signaling ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients

10.18632/oncotarget.7189 ◽

2016 ◽

Vol 7 (11) ◽

pp. 12404-12413 ◽

Author(s):

Shang-Gin Wu ◽

Yi-Nan Liu ◽

Meng-Feng Tsai ◽

Yih-Leong Chang ◽

Chong-Jen Yu ◽

...

Keyword(s):

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase

Download Full-text

Squamous cell carcinoma transformation of lung adenocarcinoma after tyrosine kinase inhibitor therapy: Cytological approach

Cytopathology ◽

10.1111/cyt.12813 ◽

2020 ◽

Vol 31 (3) ◽

pp. 232-235 ◽

Author(s):

Alexandra Grosse ◽

Claudia Grosse

Keyword(s):

Squamous Cell Carcinoma ◽

Tyrosine Kinase ◽

Lung Adenocarcinoma ◽

Tyrosine Kinase Inhibitor ◽

Cell Carcinoma ◽

Squamous Cell ◽

Kinase Inhibitor ◽

Inhibitor Therapy ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

New insights into acquired resistance mechanisms to third-generation EGFR tyrosine kinase inhibitor therapy in lung cancer

Annals of Oncology ◽

10.1093/annonc/mdz063.030 ◽

2019 ◽

Vol 30 ◽

pp. ii51

Author(s):

J. Fassunke ◽

C. Heydt ◽

S. Michels ◽

B. Van Veggel ◽

F. Müller ◽

...

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Resistance Mechanisms ◽

Third Generation ◽

Egfr Tyrosine Kinase Inhibitor ◽

Egfr Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor Therapy

Download Full-text

Targeting c-Myc to overcome acquired resistance of EGFR mutant NSCLC cells to the third generation EGFR tyrosine kinase inhibitor, osimertinib

Cancer Research ◽

10.1158/0008-5472.can-21-0556 ◽

2021 ◽

pp. canres.0556.2021

Author(s):

Lei Zhu ◽

Zhen Chen ◽

Hongjing Zang ◽

Songqing Fan ◽

Jiajia Gu ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Third Generation ◽

Egfr Tyrosine Kinase Inhibitor ◽

The Third ◽

Egfr Tyrosine Kinase ◽

Download Full-text